The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a website dedicated to reporting adverse effects of medicines or medical devices while treating Covid-19 patients.
According to the MHRA, reporting on the Yellow Card website will enable the regulator “to rapidly identify” new and emerging side effects of medicines on patients and “medical device issues which may not have been previously known about, including diagnostics tests for Covid 19.”
“This includes any medicines taken by patients to manage long-term, or pre-existing conditions that may influence the disease or have any potential interactions,” the MHRA added.
The regulator noted that any healthcare product used in the treatment of COVID-19 can be reported, including medical devices such as ventilators and respiratory support devices, testing kits, some protective personal equipment and medicines falsely claiming to cure a patient.
In a communication published on Tuesday (May 5), Dr June Raine, chief executive of the MHRA, said: “We appreciate that healthcare professionals are under pressure at this challenging time, but reporting remains essential both to understand the safety of existing medicines and medical devices used in treating COVID-19, and to identify new safety issues.”